These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27557706)

  • 1. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
    Cleveland NK; Rodriquez D; Wichman A; Pan I; Melmed GY; Rubin DT
    Dig Dis Sci; 2016 Oct; 61(10):2972-2976. PubMed ID: 27557706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Caldera F; Saha S; Wald A; Garmoe CA; McCrone S; Megna B; Ley D; Reichelderfer M; Hayney MS
    Dig Dis Sci; 2018 Jun; 63(6):1532-1540. PubMed ID: 29594970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease.
    Dezfoli S; Horton HA; Thepyasuwan N; Berel D; Targan SR; Vasiliauskas EA; Dubinsky M; Shih DQ; Kaur M; McGovern DP; Ippoliti A; Feldman EJ; Melmed GY
    Inflamm Bowel Dis; 2015 Aug; 21(8):1754-60. PubMed ID: 25985242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.
    Caldera F; Misch EA; Saha S; Wald A; Zhang Y; Hubers J; Megna B; Ley D; Reichelderfer M; Hayney MS
    Dig Dis Sci; 2019 Jan; 64(1):189-195. PubMed ID: 30317494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies.
    García-Serrano C; Mirada G; Marsal JR; Ortega M; Sol J; Solano R; Artigues EM; Estany P
    BMC Public Health; 2020 May; 20(1):713. PubMed ID: 32429900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
    Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.
    Tanriover MD; Soyler C; Ascioglu S; Cankurtaran M; Unal S
    Eur J Intern Med; 2014 Jul; 25(6):528-32. PubMed ID: 24814432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.
    Fiorino G; Peyrin-Biroulet L; Naccarato P; Szabò H; Sociale OR; Vetrano S; Fries W; Montanelli A; Repici A; Malesci A; Danese S
    Inflamm Bowel Dis; 2012 Jun; 18(6):1042-7. PubMed ID: 21674732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis.
    Eberhardt CS; Blanchard-Rohner G; Lemaître B; Boukrid M; Combescure C; Othenin-Girard V; Chilin A; Petre J; de Tejada BM; Siegrist CA
    Clin Infect Dis; 2016 Apr; 62(7):829-836. PubMed ID: 26797213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
    Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn.
    Vilajeliu A; Goncé A; López M; Costa J; Rocamora L; Ríos J; Teixidó I; Bayas JM;
    Vaccine; 2015 Feb; 33(8):1056-62. PubMed ID: 25573035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization history of children with inflammatory bowel disease.
    Soon IS; deBruyn JC; Wrobel I
    Can J Gastroenterol; 2013 Apr; 27(4):213-6. PubMed ID: 23616959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
    Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
    Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Banaszkiewicz A; Gawronska A; Klincewicz B; Kofla-Dłubacz A; Grzybowska-Chlebowczyk U; Toporowska-Kowalska E; Malecka I; Stryczynska-Kazubska J; Feleszko W; Lazowska-Przeorek I; Karolewska-Bochenek K; Walkowiak J; Slusarczyk J; Radzikowski A; Demkow U; Albrecht P
    Inflamm Bowel Dis; 2017 May; 23(5):847-852. PubMed ID: 28394806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pertussis immunity status in schoolchildren immunized with whole-cell vaccine.
    Duranoglu L; Sönmez C; Vurucu S; Kurtoglu D; Kesik V; Coplu N; Koseoglu V; Esen B; Ozcan O
    Epidemiol Infect; 2010 Feb; 138(2):299-303. PubMed ID: 19580694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Martinelli M; Giugliano FP; Strisciuglio C; Urbonas V; Serban DE; Banaszkiewicz A; Assa A; Hojsak I; Lerchova T; Navas-López VM; Romano C; Sladek M; Veres G; Aloi M; Kucinskiene R; Miele E
    Inflamm Bowel Dis; 2020 Aug; 26(9):1407-1414. PubMed ID: 31689349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
    Urganci N; Kalyoncu D
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.